Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2010
-
By Sarah Fendrick — On March 25, 2010, U.S. Patent and Trademark Office Director David Kappos appeared before the House Subcommittee on Commerce, Justice, Sciences, and Related Agencies for the Committee on Appropriations to seek funds for FY 2011 to enable USPTO operations and to fund a variety of Office initiatives and programs. The…
-
By Kevin E. Noonan — Albeit a bit anticlimactically, a study published in the journal Genomics assesses the patentability of one of the claims invalidated on Monday by Judge Robert W. Sweet of the Southern District of New York in Association of Molecular Pathology v. U.S. Patent and Trademark Office. The study is interesting…
-
Association of Molecular Pathology v. U.S. Patent and Trademark Office By Kevin E. Noonan — Not surprisingly, Judge Robert W. Sweet of the Southern District of New York ruled in favor of the plaintiffs today in Association of Molecular Pathology v. U.S. Patent and Trademark Office, granting partial summary judgment that the claims of…
-
By Donald Zuhn — On Thursday, Rep. Darrell Issa (R-CA) introduced a bill in the House (H.R. 4954) that would amend 35 U.S.C. § 292(b) to permit "[a] person who has suffered a competitive injury as a result of a violation of this section may file a civil action in a district court of…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office sent out an e-mail alert on March 26, 2010 advising that it has been informed by the International Bureau of the World Intellectual Property Organization (WIPO) that the European Patent Office (EPO) will decrease its search fee when acting as the International Search…
-
By Donald Zuhn — Earlier this month, the Federal Circuit, in In re Arora, affirmed a decision of the Board of Patent Appeals and Interferences affirming the rejection of claims 11-16 of Appellant Arun Arora's application as being obvious in view of U.S. Patent Nos. 6,978,286 and 5,934,273. Claims 11-16 of Dr. Arora's application…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Biogen Idec, Inc. et al. v. Glaxosmithkline LLC et al.3:10-cv-00608; filed March 24, 2010 in the Southern District of California • Plaintiffs: Biogen Idec, Inc.; Genentech, Inc.• Defendants: Glaxosmithkline LLC; Glaxo Group Ltd. Infringement…
-
March 30, 2010 – "The Bilski Decision: Expert Strategies to Manage Its Impact on University IP" (Technology Transfer Tactics) – 1:00 – 2:30 PM (EST) April 7, 2010 – First Annual Board Conference (U.S. Patent and Trademark Office Board of Patent Appeals and Interferences) – Alexandria, VA April 7-10, 2010 – 25th Annual Intellectual Property…
-
The George Washington University Law School (with Howrey LLP and Cornerstone Research) will be holding its second annual Law Symposium on Intellectual Property on May 11, 2010 on The George Washington University Law School, at 2000 H Street NW, Washington, DC. The Symposium will will offer presentations on the following topics: • Keynote Address —…
-
Pharma IQ will be holding its 5th Annual Pharmaceutical & Biotech Patent Litigation Strategies conference on May 24-26, 2010 in London, England. The conference will allow attendees to: • Protect a patent portfolio through implementation of the best practice policy and efficient management strategies;• Discover the intricate relationship between the EPO and the London Patents…
Patent Docs 